Intra-Cellular Therapies up on beating Q3 sales estimates

Intra-Cellular Therapies

03/11/2022 15:51

** Intra-Cellular Therapies Inc's shares  ITCI.O  rise 10.2%
to $50.5 - biggest one-day pct gain in nearly 6 months
    ** Drugmaker's Q3 sales of $71.9 mln comes in above
analysts' estimates of $66 mln - Refinitiv IBES data
    ** Co posts net loss of $53.5 mln, or $0.57 per share,
compared with a net loss of $76.9 mln, or $0.95 per share, a
year ago  urn:newsml:reuters.com:*:nGNXbkpKdg
    ** Including session gains, stock had fallen ~3% YTD 
 (Reporting by Khushi Mandowara)
 ((Khushi.Mandowara@thomsonreuters.com;))